Is Clorox's International Expansion Key to Its Long-Term Success?

The Clorox Company’s CLX international expansion is emerging as a critical lever for its long-term success, particularly as growth in its mature domestic markets begins to slow. The company is increasingly focused on scaling its presence in high-growth emerging markets such as Latin America and Asia, where rising middle-class populations and shifting hygiene habits are driving stronger demand for branded household and cleaning products.

A broader international presence could help Clorox reduce its reliance on the U.S. market, unlock new growth avenues and support more sustainable long-term revenue expansion. However, successfully executing this strategy will depend on the company’s ability to navigate currency volatility, regulatory complexities and competitive pressures in these diverse markets. The company aims to unlock greater potential in its International segment by building on the success of its Go Lean strategy, emphasizing product innovation and operational efficiency across key global markets.

In second-quarter fiscal 2026, CLX’s International segment saw a 7% rise in net sales of $294 million due to price mix, favorable foreign exchange rates and increased volumes. Organic sales also grew 5%. Segment adjusted EBIT surged 48%, mainly due to higher net sales and cost savings. We expect CLX’s international segment’s sales to increase 5% in the third quarter and 0.5% in fiscal 2026.

To succeed internationally, Clorox must carefully balance brand recognition with pricing power, while continuing to invest in localized product innovation and adapting to diverse regulatory environments across markets. Building strong brand equity is essential, but maintaining competitive pricing is equally important, particularly in emerging economies where consumers remain price sensitive. Currency fluctuations, supply-chain complexities and economic volatility in emerging markets further complicate its global push, demanding strategic agility and long-term commitment. 

Looking ahead, international expansion remains a promising pathway for Clorox to diversify revenue streams. With targeted investments and a disciplined approach, the company can position itself as a global consumer staples contender. In the long run, success abroad could be instrumental in driving both top-line growth and shareholder value.

CLX’s Price Performance, Valuation & Estimates

Shares of Clorox have gained 12.6% in the past three months compared with the industry’s growth of 10.6%

From a valuation standpoint, CLX is trading at a forward price-to-earnings ratio of 17.40X compared with the industry’s average of 19.03X.

The Zacks Consensus Estimate for CLX’s fiscal 2026 earnings implies a year-over-year decline of 23.5%, while that of fiscal 2027 shows growth of 15.3%. The company’s EPS estimate for fiscal 2026 has moved north, while that of fiscal 2027 has moved south in the past 30 days.

Clorox stock currently carries a Zacks Rank #3 (Hold).

Stocks to Consider in the Consumer Staples Space

Freshpet, Inc. FRPT, which is a pet food company, currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. 

The Zacks Consensus Estimate for Freshpet’s current financial-year sales indicates growth of 8.5% from the prior-year level. FRPT delivered a trailing four-quarter earnings surprise of 50%, on average.

Nomad Foods Limited NOMD, which manufactures and distributes frozen foods, currently carries a Zacks Rank of 2.

The Zacks Consensus Estimate for Nomad Foods’ current financial-year earnings is expected to rise 6.2% from the year-ago reported figure. NOMD delivered a trailing four-quarter earnings surprise of 2.9%, on average.

Medifast, Inc. MED, which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters. 

The Zacks Consensus Estimate for Medifast’s current financial-year earnings indicates growth of 30.5% from the year-ago number. 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research